IRONWOOD PHARMACEUTICALS, INC. Notes Payable, Current
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Notes Payable, Current of $48.80 million as of 2019-06-30, per its 10-Q filed 2019-07-30.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:NotesPayableCurrent · last filed 2020-02-13
- 2019-06-30: Notes Payable, Current $48.80M.
- 2019-03-31: Notes Payable, Current $45.96M.
- 2018-12-31: Notes Payable, Current $47.55M.
- 2018-09-30: Notes Payable, Current $39.19M.
| Period end | Notes Payable, Current |
|---|---|
| 2019-06-30 | $48.80M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $45.96M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $47.55M 10-K · filed 2020-02-13 |
| 2018-09-30 | $39.19M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $24.86M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $11.96M 10-Q · filed 2018-05-04 |
| 2016-09-30 | $8.40M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $35.26M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $28.24M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $24.96M 10-K · filed 2017-02-22 |
| 2015-09-30 | $20.12M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $17.57M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $13.21M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $11.26M 10-K · filed 2016-02-19 |
| 2014-09-30 | $9.35M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $6.58M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $4.38M 10-Q · filed 2014-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |